At least 83 percent of the United States’ largest patient advocacy groups take contributions from the drug industry, and not all of them are transparent about it.

Robert Califf, the just-departed commissioner of the U.S. Food and Drug Administration, offers his take on the Trump administration’s plans to speed up drug approvals and dramatically reduce regulations at the agency.

Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.

The new Health and Human Services secretary could quickly change the course of health policy in the United States, affecting everything from women’s healthcare to tobacco regulation.

U.S. Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading, despite the fact that a House committee he was on was under investigation.

Autism researchers and advocates alike are sounding the alarm about Betsy DeVos, President Donald Trump’s pick for U.S. secretary of education.

Watch the complete replay of David Mandell’s webinar discussing healthcare, education and autism.

The Affordable Care Act brought coverage to thousands of children in a state that had one of the highest rates of uninsured minors in the United States.

The California Department of Health Care Services says this was the first fine imposed against one of its Medicaid managed care plans since at least 2000.

President Trump’s comments on vaccines’ supposed link to autism and his proposed agency appointments are spurring scientists to take political action.